Is Bayer AG a good investment? Bayer AG (BAYN.SW) is currently trading at 44.18 EUR.
In terms of valuation, the stock trades at a P/E ratio of 7.87. This relatively low multiple may signal that Bayer AG is undervalued compared to historical market norms.
Earnings Schedule: Bayer AG is expected to release its next earnings report on Aug. 4, 2026.
For income investors, Bayer AG pays a dividend yield of 0.23%. With a payout ratio of -6%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.11 EUR (0.23% yield).
Bayer AG is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of -2.04.
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.10 EUR
|
| April 30, 2027 (estimated) | 0.1020 |
| ▸2026 |
0.10 EUR
|
| April 29, 2026 | 0.1020 |
| ▸2025 |
0.10 EUR
|
| April 30, 2025 | 0.1033 |
| ▸2024 |
0.11 EUR
|
| May 2, 2024 | 0.1075 |
| ▸2023 |
2.36 EUR
|
| May 4, 2023 | 2.3608 |
| ▸2022 |
2.00 EUR
|
| May 4, 2022 | 2.0000 |
| ▸2021 |
2.21 EUR
|
| April 30, 2021 | 2.2079 |
| ▸2020 |
2.80 EUR
|
| May 4, 2020 | 2.8000 |
| ▸2019 |
2.80 EUR
|
| May 2, 2019 | 2.8000 |
| ▸2018 |
2.80 EUR
|
| May 30, 2018 | 2.8000 |
| ▸2017 |
2.70 EUR
|
| May 4, 2017 | 2.7000 |
| ▸2016 |
2.50 EUR
|
| May 2, 2016 | 2.5000 |
| ▸2015 |
2.25 EUR
|
| May 28, 2015 | 2.2500 |
| ▸2014 |
2.10 EUR
|
| April 30, 2014 | 2.1000 |
| ▸2013 |
1.90 EUR
|
| April 29, 2013 | 1.9000 |
| ▸2012 |
1.65 EUR
|
| April 30, 2012 | 1.6500 |
| ▸2011 |
1.50 EUR
|
| May 2, 2011 | 1.5000 |
| ▸2010 |
2.04 EUR
|
| May 3, 2010 | 2.0381 |
| ▸2009 |
2.14 EUR
|
| May 13, 2009 | 2.1443 |
| ▸2008 |
2.22 EUR
|
| April 28, 2008 | 2.2154 |
| ▸2007 |
1.67 EUR
|
| April 30, 2007 | 1.6716 |
| ▸2006 |
1.51 EUR
|
| May 2, 2006 | 1.5091 |
| ▸2005 |
0.86 EUR
|
| May 2, 2005 | 0.8588 |
| ▸2004 |
0.79 EUR
|
| May 3, 2004 | 0.7913 |
| ▸2003 |
1.37 EUR
|
| April 28, 2003 | 1.3715 |
| ▸2002 |
1.34 EUR
|
| April 29, 2002 | 1.3377 |
| ▸2001 |
1.40 EUR
|
| April 30, 2001 | 1.4000 |
| ▸2000 |
1.30 EUR
|
| May 2, 2000 | 1.3000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Bayer AG | Apr 29, 2026 | Paid | 0.10196 EUR |
| Split Date | Split Ratio to 1 |
|---|---|
| June 6, 2018 | 1.020000 |
Community Discussion